SpermQT

About Inherent Biosciences

Inherent Biosciences is a private, commercial-stage diagnostics company leveraging epigenetic profiling and AI to create predictive tests for reproductive health. Its flagship product, SpermQT, marketed through its Path Fertility division, analyzes epigenetic patterns in sperm to provide personalized fertility insights and treatment guidance. The company is backed by a team of molecular biologists, data scientists, and clinical advisors, with ambitions to expand its epigenetic platform into other disease indications beyond reproductive health.

Therapeutic Areas